A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Authors: Alberto Chiappori, Tatjana Kolevska, David R. Spigel, Steven Hager, Mark U. Rarick, Shirish M. Gadgeel, Normand Blais, Joachim von Pawel, L. Hart, Martin Reck, Ekaterina Bassett, Bart Burington, Joan H. Schiller - Annals of Oncology 2014 cited by 178